ClinicalTrials.gg
RecruitingNCT06250127Updated Feb 12, 2024

The Effectiveness of Modified 3D Printed Customized Facemask Appliance for Treatment of Class III Malocclusion

An interventional study of Modified 3D printed facemask and Conventional facemask appliance in Jaw Protrusions, sponsored by University of Baghdad. Recruiting at 2 sites in Iraq. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-12.

Sponsored by University of Baghdad · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 5 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 1 month after the study started (first participant enrolled Dec 2022, registered Jan 2024).
  • Started Dec 2022; still recruiting 3 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

A randomized clinical trial to introduce a modified 3D printed customized maxillary protraction facemask and evaluate its efficacy in comparison with the conventional maxillary protraction facemask therapy in correction of Class III malocclusion of young patients

Read the detailed description

It is a multicenter randomized clinical trial with two parallel arms. The patients will be randomly divided into two groups, group one: conventional facemask appliance will be used while group two, the modified facemask appliances. Lateral cephalometric x-ray, Study models, photographs, and patient questionnaire will be taken before starting the treatment (T0) and at the end of treatment (T1). The effectiveness of the two appliances will be assessed and measured comparing patient's records before and after treatment.

02

Conditions studied

  • Jaw Protrusions

Keywords

  • Orthopedic appliance
  • Maxillary protraction
  • Petit facemask
  • Cl III malocclusion
03

In context

Malocclusion, Angle Class III

57 studies on the registry are indexed under Malocclusion, Angle Class III; 11 are open to participants now.

This study's planned enrollment of 34 is close to the median of 32 across 53 interventional studies indexed under Malocclusion, Angle Class III.

Browse Malocclusion, Angle Class III studies →

Lead sponsor

University of Baghdad is the lead sponsor of 170 studies on the registry; 69 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Skeletal and dental relationships: skeletal class III with retrognathic maxilla and normal mandible with overjet \< 0 mm.
  2. Concave profile with normal lower facial height (clinically and radiographically).
  3. Good oral health free from caries and periodontal problems at the start of treatment.

Exclusion criteria

Exclusion Criteria:

  1. Previous history of orthopedic and/or orthodontic treatment.
  2. Patients with vertical growth pattern or backward mandibular rotation tendency.
  3. Patients with gross facial asymmetry.
  4. Patients with cleft lip and palate and/or craniofacial syndrome
  5. Patients with bad oral habit.
  6. Active periodontal disease.
  7. Previous history of TMJ signs or symptoms
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
34 participants (estimated)

Study arms

  • Active comparator
    Group 1 (Conventional facemask)

    Conventional facemask appliance will be used for growing patients who have Cl. III malocclusion.

    Device: Conventional facemask appliance

  • Experimental
    Group 2 (Modified 3D printed facemask)

    Modified facemask appliances will be used for growing patients who have Cl. III malocclusion.

    Device: Modified 3D printed facemask

Interventions

  • DeviceModified 3D printed facemask

    modified 3D printed customized maxillary protraction facemask will be used for growing patients who have Cl. III malocclusion, hyrax expansion appliance and applying an elastic force of 300-500 gram per side for 12-14 hours per day. Treatment time 9 months.

  • DeviceConventional facemask appliance

    Conventional facemask appliance will be used for growing patients who have Cl. III malocclusion, hyrax expansion appliance and applying an elastic force of 300-500 gram per side for 12-14 hours per day. Treatment time 9 months.

06

What researchers measure

Primary outcomes

  1. Dentoskeletal and soft tissue changes

    Cephalometric analysis will be perfomed by measured different skeletal and soft tissue points in degrees at two time (T) intervals, (T0) before starting the treatment and (T1) at 9 months after treatment.

    Time frame: (T0) before starting the treatment and (T1) after 9 months of treatments.

Secondary outcomes

  1. Skeletal and soft tissue changes

    Skeletal changes by comparing the changes of SNA, SNB and ANB angles in degrees using cephalometric x-rays at two time intervals, (T0) before starting the treatment and (T1) after 9 months of treatments.

    Time frame: (T0) before starting the treatment and (T1) after 9 months of treatments.

  2. Dental changes

    Dental changes will be evalauted by comparing over jet changes in millimeters assessed using study models.at two time intervals, (T0) before starting the treatment and (T1) after 9 months of treatments.

    Time frame: (T0) before starting any treatment and (T1) after 9 months of treatments

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06250127
Responsible party
Mushriq F. Abid (Professor, University of Baghdad) — Principal investigator
First posted
Feb 8, 2024
Start date
Dec 1, 2022
Primary completion
Jun 1, 2024 (estimated)
Completion
Aug 1, 2024 (estimated)
Last update
Feb 12, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion